![](https://www.molecular-medicine-israel.co.il/wp-content/uploads/2017/08/breastcancer-300x225.jpg)
Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity
Highlights Summary CDK2 is a core cell-cycle kinase that phosphorylates many substrates to drive progression through the cell cycle. CDK2 is hyperactivated in multiple cancers